Article
Rapid development of SARS-CoV-2 receptor binding domain-conjugated nanoparticle vaccine…
medRxiv · 2020 · Kang, Y.-F.; Sun, C.; Zhuang, Z.; Yuan, R.-Y.; Zheng, Q.-B.; Zhou, P.-P.; Li, J.-P.; Chen, X.-C.; Zhang, X.; Yu, X.-H.; Kong, X.-W.; Zhu, Q.-Y.; Xu, M.; Zhong, N.-S.; Zeng, Y.-X.; Feng, G.-K.; Ke, C.-W.; Zhao, J.-C.; Zeng, M.-S.
Key facts
| Title | Rapid development of SARS-CoV-2 receptor binding domain-conjugated nanoparticle vaccine candidate |
|---|---|
| First author | Kang, Y.-F.; Sun, C.; Zhuang, Z.; Yuan, R.-Y.; Zheng, Q.-B.; Zhou, P.-P.; Li, J.-P.; Chen, X.-C.; Zhang, X.; Yu, X.-H.; Kong, X.-W.; Zhu, Q.-Y.; Xu, M.; Zhong, N.-S.; Zeng, Y.-X.; Feng, G.-K.; Ke, C.-W.; Zhao, J.-C.; Zeng, M.-S. |
| Journal | medRxiv |
| Published | Nov 3, 2020 |
| DOI | 10.1101/2020.11.03.366138 |
| Devices mentioned | BK110039, K042152, K051299, K073490, K940422, K982100 |
| Product codes mentioned | CEK, CFN, KIP, KIT, NDS, NJT, CZJ, DFZ, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1